Table 2.
Internal validation of mapping algorithms
| All patients | Patients with HAQ less than 1 | Patients with HAQ between 1 and 2 | Patients with HAQ greater than 2 | |
|---|---|---|---|---|
| Models with HAQ covariate only | ||||
| RMSE (SD) | ||||
| MV probit | 0.196 (0.013) | 0.065 (0.003) | 0.300 (0.019) | 0.293 (0.039) |
| Beta | 0.246 (0.021) | 0.094 (0.018) | 0.376 (0.037) | 0.343 (0.011) |
| Samples where RMSE was lower in the MV probit (%) | 100 | 99.6 | 99.8 | 91.8 |
| Models with HAQ and VAS pain covariates | ||||
| RMSE (SD) | ||||
| MV probit | 0.177 (0.022) | 0.088 (0.022) | 0.226 (0.027) | 0.277 (0.031) |
| Beta | 0.196 (0.016) | 0.099 (0.014) | 0.261 (0.028) | 0.281 (0.014) |
| Samples where RMSE was lower in the MV probit (%) | 94.2 | 90.8 | 95.2 | 63.8 |